Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Park Compounding Pharmacy is recalling specific lots of TRI-MIX vials because the agency could not ensure the products were sterile.
The FDA is recalling 9 vials of Chorionic Gonadotropin Injectable Solution from Moses Lake Professional Pharmacy due to a lack of assurance of sterility.
FDA is recalling Testosterone/Anastrozole pellets from Moses Lake Professional Pharmacy because the agency cannot ensure the sterile compounded drugs are sterile.
Moses Lake Professional Pharmacy is recalling 11 syringes of Medroxyprogesterone Acetate because the FDA determined there is a lack of assurance of sterility.
Park Compounding Pharmacy is recalling 2 vials of TRI-MIX 20MCG+0.5MG+15MG/ML due to a lack of assurance of sterility. The recall affects products distributed in California.
The FDA is recalling compounded progesterone pellets from Moses Lake Professional Pharmacy because the agency cannot ensure the products are sterile.
FDA is recalling 2 syringes of injectable glutathione from Moses Lake Professional Pharmacy because the sterility of the compounded drug cannot be assured.
FDA is recalling Alprostadil Injectable Solution vials from Moses Lake Professional Pharmacy because the agency cannot assure the sterility of the compounded drug.
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling Estradiol 30 mg pellets because the company cannot ensure the products are sterile.
JD & SN Inc. is recalling six syringes of Trimix injectable solution because the company cannot guarantee the product's sterility.
FDA is recalling a compounded injectable solution due to a lack of assurance of sterility. The product is distributed nationwide.
JD & SN Inc. is recalling 120 mg testosterone pellets because the company cannot ensure the sterile compounded drugs are free from contamination.
FDA is recalling compounded injectable glutathione from Moses Lake Professional Pharmacy due to a lack of assurance of sterility.
JD & SN Inc. is recalling 6 syringes of Methylcobalamin Injectable Solution due to a lack of assurance of sterility. The recall covers all sterile human compounded drugs within their expiry.
JD & SN Inc. is recalling 150 vials of Alprostadil/Procaine Injectable Solution due to a lack of assurance of sterility.
JD & SN Inc. is recalling TRIMIX injectable solution because the agency could not ensure the product remained sterile. Patients should stop using the medication and contact their healthcare provider.
JD & SN Inc. is recalling preservative-free methylcobalamin injectable solution due to a lack of assurance of sterility.
JD & SN Inc. is recalling 2 syringes of Papaverine/Phentolamine/Prostaglandin Injectable Solution because the agency cannot assure the sterility of the compounded drug.
Moses Lake Professional Pharmacy is recalling 30 syringes of compounded injectable cyanocobalamin because the product lacks assurance of sterility.
JD & SN Inc. is recalling methylcobalamin/hydroxocobalamin syringes because the company cannot ensure the products are sterile.
JD & SN Inc. is recalling 26 syringes of Chorionic Gonadotropin/Cyanocobalamin Injectable Solution nationwide due to a lack of assurance of sterility.
FDA is recalling 64 syringes of compounded chorionic gonadotropin from Moses Lake Professional Pharmacy due to lack of assurance of sterility.
JD & SN Inc. is recalling 95 vials of Chorionic Gonadotropin because the FDA could not verify the sterility of the compounded drug.
JD & SN Inc. is recalling Testosterone/Anastrozole pellets because the FDA identified a lack of assurance of sterility for the compounded drugs.
JD & SN Inc. is recalling 5 syringes of Hydroxocobalamine/Methylcobalamine Injectable Solution due to a lack of assurance of sterility.